MEIHAO GROUP (01947) announces annual results: shareholders' net loss of 14.341 million yuan, a decrease of 55.77% year-on-year.
Mehou Group (01947) announced its annual performance for the year ending December 31, 2025. The group achieved a profit of 102 million yuan, an increase of 36.16% year-on-year. The loss attributable to owners of the parent company narrowed to 14.341 million yuan, a decrease of 55.77% year-on-year. Basic loss per share was 2.46 cents.
MEIHAO GROUP (01947) announced its annual performance for the year ended December 31, 2025. The group achieved a revenue of 102 million yuan, a year-on-year increase of 36.16%. The loss attributable to owners of the parent company was 14.341 million yuan, a year-on-year decrease of 55.77%, with a basic loss per share of 2.46 cents.
The announcement stated that the significant increase in revenue was mainly due to the significant increase in business volume of medical institutions such as Lucheng Hospital, Wenzhou Dental, Ou Hai Jie Laiya Outpatient Department, and Leqing Hospital, as well as the continuous optimization of diagnosis and treatment services. At the same time, Wenzhou Hospital maintained stable contributions, with various hospital districts working together to drive rapid overall revenue growth.
Related Articles

CHANGMAO BIO (00954) announced a net loss attributable to shareholders of approximately 66.763 million yuan in 2025, a year-on-year decrease of 2.17%.

CHONGQING IRON (01053) appointed Li Haifeng as the company's Senior Vice President.

US Stock Market Move | Sysco Corporation (SYY.US) made a bold move to acquire for 29 billion US dollars, causing its stock price to plummet by nearly 12%.
CHANGMAO BIO (00954) announced a net loss attributable to shareholders of approximately 66.763 million yuan in 2025, a year-on-year decrease of 2.17%.

CHONGQING IRON (01053) appointed Li Haifeng as the company's Senior Vice President.

US Stock Market Move | Sysco Corporation (SYY.US) made a bold move to acquire for 29 billion US dollars, causing its stock price to plummet by nearly 12%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


